Systematic development and optimization of a microfluidic formulation protocol for liposomal azithromycin.

RSC Pharm · 2026 · PMC12633639 · PMID 41280506

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Counter to trends observed with size and PDI, EE% of the liposomes generally exhibit a decreasing trend with the increased mole ratio of AZM ( Fig. 3D ).

also in 47,180 other papers

an increasing trendno p-value reported

The size and PDI of the liposomes follow an increasing trend with the increased mole ratio of AZM ( Fig. 3B ).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.